ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Skilarence 120mg, magensaftresistente Tablette - 180
66703003 Almirall AG
Skilarence 120mg, magensaftresistente Tablette28.01.2019
  28.01.2019
Dimethyl Fumarate (L04AX07) 
WHO-DDD 
10.03.180
10.03. 
B  
No 
IP 
357.15  
k.A.426.40
7680667030034Synthetika
  
Composition
dimethylis fumaras 120 mg, lactosum monohydricum 144 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas, polysorbatum 80, talcum, triethylis citras, simeticonum, E 132, E 171, natrii hydroxidum, pro compresso obducto corresp. natrium 1.94 mg.
Packungsbestandteile
Gastric juice resistant tablets 
 
Active AgentDose
Dimethylis Fumaras120 mg
BAG: Active AgentDose
Dimethylis Fumaras120 mg
 
Inactive agentsDoseadditional_information
Acidi Methacrylici Überzug
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 132 color.
E 171 color.
Ethylis Acrylatis Polymerisatum  
Lactose Monohydrate144 mg 
Magnesii Stearas  
Sodium Hydroxide  
Natrii Laurilsulfas  
Polysorbatum 80  
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Simeticone  
Talcum  
Triethylis Citras  
 
Source
Data was imported : 07.07.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home